– Reuters
Why Trinity Biotech Stock Is Moving Up Today
Trinity Biotech (NASDAQ: TRIB) shares are trading higher after the company announced the sale of its Fitzgerald Industries life sciences business.
Related Posts
Credit Suisse Initiates Coverage On Goosehead Insurance with Outperform Rating, Announces Price Target of $72
Credit Suisse analyst Andrew Kligerman initiates coverage on Goosehead Insurance (NASDAQ:GSHD) with a Outperform rating and announces Price Target of $72.
Deutsche Bank Maintains Hold on NVIDIA, Raises Price Target to $150
Deutsche Bank analyst Ross Seymore maintains NVIDIA (NASDAQ:NVDA) with a Hold and raises the price target from $140 to $150.